kr 19.54 ($1.94)

-0.14 (-0.71%)

Weekly Expected Move ±4.8%

kr 18 kr 19 kr 20 kr 20 kr 21

STO · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · kr 1.3B mcap · 57M float · 0.189% daily turnover

Analysis Technicals Weather Peers

Revenue

$129M -1.1% ▼

5Y CAGR: +16.1%

Gross Profit

$27M -76.1% ▼

5Y CAGR: -13.8%

Operating Income

$27M -39.9% ▼

5Y CAGR: +31.9%

Net Income

$23M -28.6% ▼

5Y CAGR: +29.5%

EPS (Diluted)

$0.36 -28.0% ▼

5Y CAGR: +29.5%

EBITDA

$40M -29.2% ▼

5Y CAGR: +35.9%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$93M	$102M	$158M	$130M	$129M
YoY Growth	+52.4%	+10.1%	+54.5%	-17.6%	-1.1%
Cost of Revenue	$12M	$15M	$15M	$15M	$101M
Gross Profit	$81M	$87M	$143M	$115M	$27M
Gross Margin	87.4%	85.3%	90.4%	88.2%	21.3%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$22M	$68M	$88M	$76M	$0
Operating Expenses	$60M	$74M	$89M	$69M	$95M
Operating Income	$25M	$22M	$54M	$46M	$27M
Operating Margin	26.4%	22.0%	34.3%	35.1%	21.3%
Interest Expense	$0	$338K	$2M	$4M	$1M
Income Before Tax	$25M	$8M	$55M	$46M	$27M
Tax Expense	-$174K	-$3M	-$7M	$13M	$3M
Net Income	$25M	$11M	$62M	$33M	$23M
Net Margin	26.6%	10.9%	38.9%	25.3%	18.2%
EPS (Diluted)	$0.38	$0.17	$0.94	$0.50	$0.36
EBITDA	$29M	$15M	$67M	$56M	$40M
Shares Outstanding	65M	65M	65M	65M	66M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$33M	$28M	$32M	$29M	$28M	$40M	$34M	$34M
Cost of Revenue	$4M	$3M	$3M	$3M	$3M	$4M	$4M	$3M
Gross Profit	$29M	$25M	$29M	$26M	$25M	$36M	$30M	$31M
Gross Margin	87.9%	88.1%	89.8%	90.8%	90.3%	88.9%	88.5%	90.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$18M	$19M	$17M	$0	$0	$0	$0	$0
Operating Expenses	$7M	$19M	$23M	$23M	$21M	$28M	$24M	$28M
Operating Income	$22M	$5M	$6M	$3M	$3M	$8M	$6M	$3M
Operating Margin	67.0%	19.1%	19.8%	12.0%	12.3%	20.0%	17.2%	8.2%
Interest Expense	$0	$0	$115K	$172K	$358K	$0	$301K	$0
Income Before Tax	$22M	$6M	$6M	$4M	$9M	$8M	$5M	$3M
Tax Expense	$8M	$1M	$3M	-$1M	$1M	$793K	$1M	$1M
Net Income	$14M	$5M	$3M	$5M	$8M	$7M	$4M	$1M
Net Margin	41.9%	16.4%	10.7%	17.7%	29.2%	17.1%	12.7%	3.8%
EPS (Diluted)	$0.21	$0.07	$0.05	$0.08	$0.12	$0.10	$0.06	$0.02
EBITDA	$25M	$8M	$9M	$6M	$7M	$12M	$10M	$7M
Shares Outstanding	65M	65M	65M	65M	66M	66M	66M	67M

GENO.ST STO